NO-tissue plasminogen activator
Alternative Names: NO-tPALatest Information Update: 19 Mar 2008
Price :
$50 *
At a glance
- Originator NitroMed
- Class Plasminogen activator enzymes
- Mechanism of Action Fibrinolytic agents; Nitric oxide donors; Plasminogen activator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery restenosis; Myocardial infarction
Most Recent Events
- 06 Mar 2008 NitroMed's nitric oxide-enhancing technologies are available for licensing
- 28 Sep 1999 Preclinical development for Coronary artery restenosis in USA (Parenteral)
- 28 Sep 1999 Preclinical development for Myocardial infarction in USA (Parenteral)